<img alt="" src="https://secure.intelligent-consortium.com/791519.png" style="display:none;">

Psomagen Announces PacBio Revio Sequencing Capabilities for North American Customers

Psomagen Blog

Psomagen Announces PacBio Revio Sequencing Capabilities for North American Customers


ROCKVILLE, Md. — June 23, 2023 — Psomagen is pleased to announce the arrival of our newest sequencing platform, the Pacific Biosciences Revio system.

The Revio can produce 360 Gb of HiFi reads per day, compared to the Sequel IIe’s 24 GB per day. That’s 1,300 whole human genomes in a year. In a single run, this technology provides small variants, structural variants, repeat expansions, methylation, and haplotype phasing. With four independent stages, the Revio can sequence multiple samples and applications simultaneously. It has applications in genomics, epigenomics, and transcriptomics. 

PacBio’s Revio system has added additional long-read NGS to Psomagen’s current fleet of short- and long-read next-generation sequencers and microarray systems, offering services like whole genome, whole exome, single cell and bulk RNAseq, microbiome, Olink Proteomics and additional applications. 

“We’re delighted to add another PacBio system to our services,” says Dr. Su Hong, Psomagen CEO. “Their technology is at the forefront of long-read sequencing developments. This option makes it possible to conduct massive sequencing projects faster than ever before.”

Psomagen's parent company, Macrogen, has been a PacBio Certified Service Provider since 2015. “It’s exciting to join Macrogen in offering PacBio's newest platform,” says Dr. Hong. “Technology like this allows our clients to conduct robust genetic research, and opens the door to a wider range of multiomics projects.”

About Psomagen, Inc.

Psomagen, Inc., formerly Macrogen Corp, is a North American integrative omics solutions and contract laboratory services provider. The company makes cutting-edge technology and data analysis accessible to the clinical and academic markets. With both CLIA-certified and CAP-accredited facilities, their team delivers only the highest-quality integrative multi-omics data using best-in-class DNA, RNA, and protein analysis systems. In conjunction with its bioinformatics capabilities, Psomagen offers a path to insights that is both simple and affordable. Learn more at psomagen.com.

Harold Nuñez Burgos
Product Manager
Psomagen, Inc. 

About Macrogen

Macrogen was founded in 1997 in Seoul, South Korea. In 2000, they became the first Korean bio venture to be listed on the KOSDAQ. Since then, Macrogen has expanded their reach in the genomics and genetics R&D fields. Today, the company has locations across Europe, as well as offices in Singapore, Tokyo, and Chile. Their subsidiary, Psomagen, offers multiomics services to North American customers. Macrogen continues to offer genomic analysis services to clients in over 150 countries. Learn more at macrogen.com.

About Pacific Biosciences

PacBio is a California-based provider of sequencing solutions that solve complex genomics problems. Their sequencers are designed to create more complete images of the genome, transcriptome, and epigenome. PacBio users have made contributions to rare disease research, public health surveillance, pharmaceutical development, and many other fields. Learn more at pacb.com.